INTRODUCTION
Pseudomonas aeruginosa is widely spread in humid environments such as plants, soil and a wide range of aquatic habitats, and could be colonizing in hospital environments [1] . This may include sinks, shower rooms, and bath rooms, thus, it is a common cause of nosocomial infections [1] . P. aeruginosa is a common pathogen of blood stream infections in patients with hematologic malignancy and other critical diseases [2, 3] . Blood stream infections could be associated with higher mortality rates depending on the patient's conditions [4] .
Pseudomonas aeruginosa has an intrinsic resistance to several antibiotics, because of a low permeability of the outer-membrane, various efflux pumps and production of enzymes, e.g., cephalosporinases [5] .
Furthermore, P. aeruginosa could acquire several mechanisms of resistance, such as reduced membrane permeability, target modification (DNA gyrase, methylation of 16S rRNA), and production of metallo-betalactamases. This is why it is difficult to treat infected patients. Appropriate use of antibiotics is one of the most important infection control measures [6] . Several reports indicated the correlation of antibiotic usage and resistance [7] [8] [9] . On the other hand, one report indicated no relation of antimicrobial usage and resistance of P.
aeruginosa in the hospitals in United States [10] . In our hospital, susceptibilities of P.
aeruginosa to several antibiotics declined in 2010, however, subsequently improved in 2011. In this study, we show the consumption of anti-pseudomonal antibiotics and their susceptibility to those agents in a university hospital in Japan. 
METHODS
(PIPC-TAZ), piperacillin (PIPC), meropenem (MEPM), doripenem (DRPM), imipenem- cilastatin (IPM), biapenem (BIPM), panipenem-betamipron (PAPM), ciprofloxacin (CPFX),
RESULTS

Antibiotic Utilizations
Annual consumptions of antibiotics are listed as DDD in Table 1 
Susceptibilities of P. aeruginosa to Antibiotics
Susceptibilities of P. aeruginosa to antibiotics are listed in Table 2 . Susceptibilities to cephalosporins, carbapenems except for PAPM, penicillins, and fluoroquinolones declined between 22% and 39% in 2010 and increased in the range of 16-31% in 2011, and furthermore increased by 1-14% in 2012.
Susceptibility to PAPM ranged between 25% and 32%. Susceptibility to aminoglycoside was more than 90% during this period. 
DISCUSSION
We investigated susceptibilities of P. aeruginosa to anti-pseudomonal agents and utilization of these antibiotics for 4 years. Susceptibilities of P. aeruginosa declined in 2010 and increased in the following years. However, corresponding changes in antimicrobial usages were not observed, and correlation between susceptibilities and antimicrobial usages was not seen in our data.
Several reports indicated that increased
antimicrobial usage was associated with a decline in susceptibilities or emergence of resistant P. aeruginosa. Xu et al. [8] indicated that the resistance rate of P. aeruginosa to meropenem increased 1.2% when antipseudomonal carbapenems usage increased 1 DDDs/1000 patient days. Nakamura et al. [13] reported the relation of meropenem consumption and emergence of multidrug resistant P. aeruginosa. Appropriate use of antibiotics is essential to avoid the emergence of resistant bacteria. However, antimicrobial usage is not the only factor that determines the susceptibilities of bacteria. Other infection control measures, including hand hygiene, cleaning, and antimicrobial stewardship, are also important to avoid the emergence of resistant P. aeruginosa [14] . Correlation between antibiotic usage and susceptibility of P. aeruginosa was not observed in our data or in a report by Mutnick et al. [10] . Factors other than antimicrobial usage might contribute to these results. Moreover, the usages of anti-pseudomonal antibiotics, except carbapenems, in the report by Xu et al. [8] were three to five times higher than in our hospital.
Initial resistance rates of P. aeruginosa to aminoglycoside and fluoroquinolones in the report were significantly higher than our data, nevertheless, we used more strict breakpoints according to CLSI M100-S23. We evaluated only blood samples, because we considered causative bacteria of infection more important than those of colonization, while other reports included colonized strains. These factors might affect the result. We compared the total usage of antibiotics in the hospital and susceptibilities of all isolates of P. aeruginosa in the hospital, while correlations might be observed in wards with a high consumption of antibiotics, such as the intensive care unit (ICU). Loeffler et al. [15] reported that correlation between antibiotic consumption and resistance in ICU was observed for piperacillin, cephalosporins and aminoglycosides in P. aeruginosa. However, Slain et al. [16] 
